Table 3 Final clinical parameters according to the M-CHARTS-detected metamorphopsia in patients with resolved central serous chorioretinopathy
With metamorphopsia (n = 19) | Without metamorphopsia (n = 17) | P value | |
|---|---|---|---|
BCVA (logMAR) | 0.1 ± 0.3 | 0.1 ± 0.2 | 0.312 |
Central foveal thickness (μm) | 159.4 ± 37.4 | 187.5 ± 32.6 | 0.013 |
Outer nuclear layer thickness (μm) | 74.7 ± 25.0 | 94.5 ± 18.6 | 0.015 |
Pigment epithelial detachment (n, %) | 2, 10.5 % | 4, 23.5 % | 0.391 |
RPE irregularities (n, %) | 13, 68.4 % | 5, 29.4 % | 0.019 |
External limiting membrane | <0.001 | ||
Intact (n, %) | 2, 10.5 % | 13, 76.5 % | |
Focal disruption (n, %) | 6, 31.6 % | 2, 11.8 % | |
Broad disruption (n, %) | 11, 57.9 % | 2, 11.8 % | |
Photoreceptor IS/OS junction | 0.012 | ||
Intact (n, %) | 0, 0 % | 7, 41.2 % | |
Focal disruption (n, %) | 6, 31.6 % | 5, 29.4 % | |
Broad disruption (n, %) | 13, 68.4 % | 5, 29.4 % | |
COST line | 0.002 | ||
Intact (n, %) | 0, 0 % | 0, 0 % | |
Focal disruption (n, %) | 2, 10.5 % | 10, 58.8 % | |
Broad disruption (n, %) | 17, 89.5 % | 7, 41.2 % |